Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

por Lanning, Nathan J., Castle, Joshua P., Singh, Simar J., Leon, Andre N., Tovar, Elizabeth A., Sanghera, Amandeep, MacKeigan, Jeffrey P., Filipp, Fabian V., Graveel, Carrie R.
Publicado 2017

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

por Linklater, Erik S., Tovar, Elizabeth A., Essenburg, Curt J., Turner, Lisa, Madaj, Zachary, Winn, Mary E., Melnik, Marianne K., Korkaya, Hasan, Maroun, Christiane R., Christensen, James G., Steensma, Matthew R., Boerner, Julie L., Graveel, Carrie R.
Publicado 2016

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

por Dischinger, Patrick S., Tovar, Elizabeth A., Essenburg, Curt J., Madaj, Zachary B., Gardner, Eve E., Callaghan, Megan E., Turner, Ashley N., Challa, Anil K., Kempston, Tristan, Eagleson, Bryn, Kesterson, Robert A., Bronson, Roderick T., Bowman, Megan J., Graveel, Carrie R., Steensma, Matthew R.
Publicado 2018